1-6 of 6
Ana R Cid
Close
Sort by
Journal Articles

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Juan Eduardo Megias, Santiago Bonanad Boix, Antonio Palomero Massanet, Manuel Rodríguez López, Mariana Canaro, Saturnino Haya, Ana R. Cid, Emilio Monte, Pau Bosch, Guillermo Sanz, José Luis Poveda Andrés
Journal: Blood
Blood (2022) 140 (Supplement 1): 11308–11309.
https://doi.org/10.1182/blood-2022-169938
Published: 2022
Journal Articles

Real-World Clinical Management of Patients with Congenital Hemophilia and Inhibitors: Interim Analysis of the FEIBA Global Outcome Study (FEIBA GO)

Cedric Hermans, MDMRCP,PhD, Claude Négrier, Pål A Holme, Carmen Escuriola, Ana R Cid, Nataliya Kemenyash, MSc, Jaco Botha, Viridiana Cano-Garcia, Jerzy Windyga
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-139298
Published: 2020
Journal Articles

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Juan Eduardo Megias, Santiago Bonanad Boix, MD, María Fernanda Martínez García, MD, Rubén Berrueco, MD, Maria Eva Mingot-Castellano, PhD MD, Manuel Rodríguez López, MD, Mariana Canaro, MD, José Mateo Arranz, MD, Itziar Larrodé Leciñena, PharmD, Saturnino Haya, MD, Amparo Santamaria Ortiz, MD, Carmen Albo, MD, Montserrat Mesegué Medea, MD, Antonio Palomero-Massanet, PharmD, Noelia Vilalta Seto, MD, José Manuel Calvo Villas, Ana R Cid, Gustavo Robayo, MD, José Luis Poveda Andrés, Guillermo F. Sanz, MD PhD, Alfonso Iorio
Journal: Blood
Blood (2019) 134 (Supplement_1): 2405.
https://doi.org/10.1182/blood-2019-127946
Published: 2019
Journal Articles

Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with >18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO)

Jerzy Windyga, Pal A Holme, C. Hermans, Ana R Cid, Nirjhar Chatterjee, Hongyu Jiang, Viridiana Cano-Garcia, Carmen Escuriola
Journal: Blood
Blood (2019) 134 (Supplement_1): 2418.
https://doi.org/10.1182/blood-2019-124324
Published: 2019
Journal Articles

Benefits of Ehl Factor VIII Replacement Therapy in Hemophilia: Observations on Coverage, Physical Activity and Phisiotherapy

Felipe Querol, MD PhD, Sofía Pérez-Alenda, PhD, Juan Eduardo Megias, Juan José Carrasco, MSc, Marta Aguilar, PhD, Saturnino Haya, MD, Ana R Cid, Santiago Bonanad Boix, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2455.
https://doi.org/10.1182/blood-2019-125651
Published: 2019
Journal Articles

Congenital Factor XIII Deficiency as Cause for Intracraneal Hemorrhage.

Maria Angeles Dasi, Prof., MD, Bienvenida Argiles, Ana R Cid, M. Carmen Carreras, J. Antonio Aznar, Maria Teresa Santos, Juana Valles, Magdalena Peinador
Journal: Blood
Blood (2009) 114 (22): 4208.
https://doi.org/10.1182/blood.V114.22.4208.4208
Published: 2009